Laryngeal Mask Airway (LMA) Insertion With Sevoflurane and Remifentanil
NCT ID: NCT01456299
Last Updated: 2019-03-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
102 participants
INTERVENTIONAL
2011-04-30
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Appropriate Remifentanil Dose for Optimal Insertion of Laryngeal Mask Airway in Adult Patients During Induction of General Anesthesia Using Remimazolam.
NCT06289829
Dose Finding Study of Remimazolam for Laryngeal Mask Airway Insertion
NCT05298228
the Effective Bolus Dose of Remifentanil for Laryngeal Mask Airway (LMA) Insertion in Children
NCT01919203
Remifentanil for the I-gel and Laryngeal Mask Airway Insertion
NCT02382354
Effect-site Concentration of Remifentanil for Smooth Removal of the Double-lumen Endotracheal Tube
NCT02528825
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
The control group, which received an infusion of normal saline.
Control
The control group, which received an infusion of normal saline
Remifentanil 1
"Remifentanil 1": "The R1 group, which received a target effect-site remifentanil concentration of 1 ng/ml.
Remifentanil 1
"Remifentanil 1": "The R1 group, which received a target effect-site remifentanil concentration of 1 ng/ml.
Remifentanil 2
"Remifentanil 2": "The R2 group, which received a target effect-site remifentanil concentration of 2 ng/ml.
Remifentanil 2
"Remifentanil 2": "The R2group, which received a target effect-site remifentanil concentration of 2 ng/ml.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remifentanil 1
"Remifentanil 1": "The R1 group, which received a target effect-site remifentanil concentration of 1 ng/ml.
Control
The control group, which received an infusion of normal saline
Remifentanil 2
"Remifentanil 2": "The R2group, which received a target effect-site remifentanil concentration of 2 ng/ml.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gachon University Gil Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hyun Jeong Kwak
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jong Yeop Kim, MD,PhD
Role: STUDY_DIRECTOR
Ajou University School of Medicine
Jong Yeop Kim, MD, PhD
Role: STUDY_DIRECTOR
Ajou Universiy School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ajou University School of Medicine
Suwon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sivalingam P, Kandasamy R, Madhavan G, Dhakshinamoorthi P. Conditions for laryngeal mask insertion. A comparison of propofol versus sevoflurane with or without alfentanil. Anaesthesia. 1999 Mar;54(3):271-6. doi: 10.1046/j.1365-2044.1999.00663.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AJIRB-MED-CT4-11-045
Identifier Type: REGISTRY
Identifier Source: secondary_id
AJIRB-MED-CT4-11-045
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.